Dow Up 1.64% Nasdaq Up 1.86%

More On CYP.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Cynata Therapeutics Limited (CYP.AX)

-ASX
0.32 Up 0.06(20.75%) 11:05PM EDT
Prev Close:0.27
Open:0.30
Bid:0.31
Ask:0.32
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.29 - 0.32
52wk Range:0.23 - 0.90
Volume:611,196
Avg Vol (3m):154,502
Market Cap:23.28M
P/E (ttm):N/A
EPS (ttm):-0.07
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.36
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cynata Therapeutics Limited, through its subsidiary, Cynata Incorporated, develops a therapeutic stem cell platform in Australia. It focuses on the development and commercialization of the Cymerus, a mesenchymal stem cell technology for human ther... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback